Hepatology International

Scope & Guideline

Advancing liver health through groundbreaking research.

Introduction

Delve into the academic richness of Hepatology International with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1936-0533
PublisherSPRINGER
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 2008 to 2024
AbbreviationHEPATOL INT / Hepatol. Int.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

Hepatology International is a multidisciplinary journal dedicated to advancing the understanding, diagnosis, and treatment of liver diseases. The journal publishes original research, reviews, and clinical studies that contribute to the field of hepatology, with a strong emphasis on the integration of clinical practice and research methodologies.
  1. Metabolic Dysfunction-Associated Liver Diseases:
    The journal focuses extensively on metabolic dysfunction-related liver diseases, particularly metabolic-associated fatty liver disease (MAFLD), exploring its pathophysiology, clinical implications, and management strategies.
  2. Hepatocellular Carcinoma (HCC) Research:
    Research on HCC is a key area, encompassing studies on its epidemiology, molecular mechanisms, risk factors, treatment modalities, and outcomes, reflecting the urgent need to address this prevalent liver cancer.
  3. Liver Transplantation and Complications:
    The journal covers various aspects of liver transplantation, including donor selection, post-transplant outcomes, complications, and innovative techniques, aiming to improve patient management and survival.
  4. Autoimmune Liver Diseases:
    Significant attention is given to autoimmune liver diseases, emphasizing their diagnosis, treatment, and long-term management, particularly in populations susceptible to these conditions.
  5. Innovative Diagnostic and Therapeutic Approaches:
    The journal promotes research on novel diagnostic techniques and therapeutic interventions, including the use of artificial intelligence in imaging, molecular markers, and emerging pharmacological treatments.
  6. Gut-Liver Axis Research:
    Research exploring the relationship between gut microbiota and liver health is increasingly highlighted, focusing on how gastrointestinal factors influence liver diseases and their progression.
Recent publications in Hepatology International showcase emerging themes that are gaining traction. These trends reflect the evolving landscape of liver disease research, highlighting areas of increasing interest and importance.
  1. MAFLD and Cardiovascular Risk:
    There is a growing body of work linking metabolic dysfunction-associated fatty liver disease (MAFLD) with cardiovascular risks, emphasizing the need for integrated approaches to manage both liver and cardiovascular health.
  2. Artificial Intelligence in Hepatology:
    The integration of artificial intelligence and machine learning techniques in diagnostic imaging and prognostic modeling is a notable trend, promising to enhance the precision of liver disease assessments and treatment planning.
  3. Personalized Medicine Approaches:
    Research focusing on personalized medicine in hepatology is on the rise, with studies exploring individualized treatment plans based on genetic, epigenetic, and metabolic profiles of patients.
  4. Immunotherapy for Hepatocellular Carcinoma:
    Emerging studies on immunotherapeutic strategies for treating hepatocellular carcinoma indicate a significant trend, reflecting the shift towards harnessing the immune system in cancer treatment.
  5. Research on Gut Microbiome Influence:
    The exploration of gut microbiota's role in liver disease progression and treatment response is increasingly prominent, highlighting its potential as a therapeutic target and diagnostic tool.

Declining or Waning

As the field of hepatology evolves, certain areas of research have shown a decline in focus within recent publications. These waning themes reflect shifts in priorities and emerging interests among researchers and clinicians.
  1. Traditional Viral Hepatitis Management:
    While viral hepatitis remains a critical area, the focus on conventional management strategies has waned in favor of more innovative approaches, such as personalized medicine and combination therapies, indicating a shift towards addressing complex cases rather than standard treatment protocols.
  2. Alcohol-Related Liver Disease Studies:
    Research specifically targeting alcohol-related liver diseases appears to be decreasing, as the emphasis has shifted towards metabolic liver diseases like MAFLD, reflecting changing demographics and health concerns.
  3. Chronic Hepatitis C Treatment:
    With the advent of highly effective direct-acting antivirals, studies focusing on long-term management and outcomes of chronic hepatitis C have diminished, as the clinical landscape has moved towards elimination and prevention strategies.
  4. Surgical Interventions for Liver Disease:
    There seems to be a decline in studies focused on surgical interventions, such as liver resections and traditional transplant techniques, with a growing interest in less invasive approaches and innovative therapies.
  5. Liver Disease in Pediatric Populations:
    While pediatric liver diseases remain important, the volume of research specifically targeting this demographic has decreased, possibly due to a shift in focus towards adult populations and the broader implications of liver health.

Similar Journals

WORLD JOURNAL OF GASTROENTEROLOGY

Leading the way in gastrointestinal research excellence.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1007-9327Frequency: 48 issues/year

WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.

Journal of Gastrointestinal and Liver Diseases

Fostering Scholarly Excellence in Gastrointestinal Science
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

Translational Gastroenterology and Hepatology

Transforming Laboratory Insights into Clinical Excellence.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Clinical Gastroenterology and Hepatology

Innovating Insights for Digestive Health
Publisher: ELSEVIER SCIENCE INCISSN: 1542-3565Frequency: 12 issues/year

Clinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.

Journal of Clinical and Experimental Hepatology

Innovating hepatology: where clinical practice meets scientific discovery.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

Hepatology Communications

Enhancing understanding of liver health worldwide.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Hepatology Communications, published by Lippincott Williams & Wilkins, serves as a pioneering platform in the field of hepatology, dedicated to advancing the understanding of liver diseases and treatments. Since its inception in 2017, this open access journal has rapidly gained recognition, achieving an impressive Q1 ranking in Hepatology as of 2023, and appealing to a diverse audience of researchers, clinicians, and students alike. With its focus on high-quality research and clinical studies, the journal aims to facilitate impactful discussions and disseminate vital findings that address the challenges faced in liver health. Operating out of the United States, and accessible globally, Hepatology Communications is committed to fostering a collaborative research environment and enhancing the visibility of scholarly work in hepatology, ultimately driving forward innovations in patient care and treatment strategies.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Transforming gastroenterology with cutting-edge research.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

Annals of Hepatology

Elevating knowledge and collaboration in liver research.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.

JHEP Reports

Driving excellence in gastroenterology and internal medicine.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Uncovering the latest in digestive health advancements.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.